Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing

Use of P13K Inhibitors for the Treatment of Obesity, Steatosis and ageing

US Patent 9993554 · Granted Jun 12, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antisense oligonucleotides and uses thereof2023
FOXP3-binding peptides and uses thereof2023
FoxP3-binding peptides and uses thereof2020
Compounds as inhibitors of DNA methyltransferases2019
Condensed tricyclic compounds as protein kinase inhibitors2019
Condensed tricyclic compounds as protein kinase inhibitors2019
Compounds for use in cognition improvement2018
Compounds as dual inhibitors of histone methyltransferases and DNA methyltransfe2017
Macrocyclic compounds as protein kinase inhibitors2017
Tricyclic compounds for use as kinase inhibitors2017
Tricyclic compounds for use as kinase inhibitors2017
Compounds as dual inhibitors of phosphodiesterases and histone deacetylases2017